Professional Documents
Culture Documents
FINALS NCM 106 Lesson 1 Part 1 Drugs Acting in The Central and Peripheral Nervous System Week 1
FINALS NCM 106 Lesson 1 Part 1 Drugs Acting in The Central and Peripheral Nervous System Week 1
FINALS NCM 106 Lesson 1 Part 1 Drugs Acting in The Central and Peripheral Nervous System Week 1
Sedation
NCM 106 – FINALS
Lesson 1 – Part 1 (Week 1)
to loss of awareness and reaction to environment Phentobarbital
For patients who are: Phenobarbital (p)
Restless Secobarbital
Nervous
Irritable Actions of these two drugs
Overreacting to stimuli
Sedation is anxiolytic and most of the time lead to
drowsiness
The extreme sedation usually results in further central
nervous system depression and sleep also this causes
hypnosis thus helping people to fall asleep.
Contraindications
- allergy to any benzodiazepines
- psychosis, acute and narrow-angle glaucoma, shock, coma
and acute alcoholic intoxication
- pregnancy and breastfeeding
Adverse Effect
- sedation, drowsiness, depression, lethargy, blurred vision,
headaches, apathy, light-headedness and confusion
- dry mouth, constipation, nausea, vomiting and elevated liver
enzymes
- arrythmias, palpations and respiratory difficulties
- urinary retention and hesitancy, loss of libido and changes in
sexual functioning.
Other Antidepressants
Bupropion (p) – Weakly blocks the reuptake of NE,
5HT and dopamine
Mirtazapine – is rapidly absorbed from GI tract,
extensively metabolized in the liver and excreted in
the urine
Nefazodone – has a short half-life of 2-4 hours
Selegiline – is a MAO type B inhibitor that has been
3. Regulate receptor sites, leading to accumulation of
and is now available as a transdermal system.
neurotransmitter
Trazodone -
Desvenlafaxine – newest SSRIs